A Prospective, Randomized, Controlled study to Evaluate the Effectiveness and Safety of CELSTAT as an Adjunct to Hemostasis for Tissue Bleeding in Cardiothoracic General and Vascular Surgery

Grants and Contracts Details

StatusFinished
Effective start/end date6/7/166/6/18

Funding

  • Baxter Healthcare Co: $14,905.00